OMF Q1 2026 Earnings EPS Beats Estimates Amid Modest Stock Pullback GT Biopharma Q1 2026 Earnings WiderthanExpected Loss Amid Continued Development BRBI Q1 2026 Earnings EPS Misses Estimates by 71 Amid Challenging Quarter STAG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gains OLB Q4 2025 Earnings Narrower Loss Beats Estimates as Stock Rises VRM Q3 2025 Earnings Loss Per Share Deepens Stock Declines Amid Missing Revenue Disclosures